Search
DEEN
more info

Contact:
Phone:+49 0761 1514 440Fax:+49 0761 1514 460Email:info[at]falkfoundation.org

    Falk Gastro Review Journal

    Current science, compiled for you from the multitude of scientific publications – this is the Falk Gastro Review Journal.

    Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

    The latest issues

    Edition 4/2024

    read more

    Edition 3/2024

    read more

    Edition 2/2024

    read more

    Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.

    All articles

    Liver and Bile

    Infliximab-induced liver injury: Clinical phenotypes, autoimmunity and the role of corticosteroid treatment

    J Hepatol. 2022;76(1):86–92

    Björnsson HK, Gudbjornsson B, Björnsson ES

    Go to article

    Liver and Bile

    Depression and anxiety are common among patients with cirrhosis

    Clin Gastroenterol Hepatol. 2022;20(1):194–203.e1

    Hernaez R, Kramer JR, Khan A, Phillips J, McCallister K, Chaffin K, Hernandez AP, Fullington H, Ortiz C, Blackwell JM, Loewen A, Liu Y, Tiro JA, Lee SC, Singal AG

    Go to article

    Liver and Bile

    Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis

    J Hepatol. 2022;76(3):588–99

    Tantai X, Liu Y, Yeo YH, Praktiknjo M, Mauro E, Hamaguchi Y, Engelmann C, Zhang P, Jeong JY, Ad van Vugt JL, Xiao H, Deng H, Gao X, Ye Q, Zhang J, Yang L, Cai Y, Liu Y, Liu N, Li Z, Han T, Kaido T, Sohn JH, Strassburg C, Berg T, Trebicka J, Hsu YC, IJzermans JNM, Wang J, Su GL, Ji F, Nguyen MH

    Go to article

    Liver and Bile

    Frailty is associated with increased risk of cirrhosis disease progression and death

    Hepatology. 2022;75(3):600–9

    Wang S, Whitlock R, Xu C, Taneja S, Singh S, Abraldes JG, Burak KW, Bailey RJ, Lai JC, Tandon P

    Go to article

    Liver and Bile

    Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: A systematic review and meta-analysis

    Dig Liver Dis. 2022;54(1):56–62

    Koh JH, Liew ZH, Ng GK, Liu HT, Tam YC, De Gottardi A, Wong YJ

    Go to article

    Liver and Bile

    Two-dimensional shear-wave elastography predicts survival in advanced chronic liver disease

    Gut. 2022;71(2):402–14

    Trebicka J, Gu W, de Ledinghen V, Aubé C, Krag A, Praktiknjo M, Castera L, Dumortier J, Bauer DJM, Friedrich-Rust M, Pol S, Grgurevic I, Zheng R, Francque S, Gottfriedovà H, Mustapic S, Sporea I, Berzigotti A, Uschner FE, Simbrunner B, Ronot M, Cassinotto C, Kjaergaard M, Andrade F, Schulz M, Semmler G, Tjesic Drinkovic I, Chang J, Brol MJ, Rautou PE, Vanwolleghem T, Strassburg CP, Boursier J, Ferstl PG, Rasmussen DN, Reiberger T, Vilgrain V, Guibal A, Guillaud O, Zeuzem S, Vassord C, Lu X, Vonghia L, Senkerikova R, Popescu A, Margini C, Wang W, Thiele M, Jansen C

    Go to article

    Liver and Bile

    Procedural bleeding risk, rather than conventional coagulation tests, predicts procedure-related bleeding in cirrhosis

    Eur J Gastroenterol Hepatol. 2022;34(2):192–9

    Janko N, Majeed A, Commins I, Kemp W, Roberts SK

    Go to article

    Liver and Bile

    Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – Development and validation of the CRAFITY score

    J Hepatol. 2022;76(2):353–63

    Scheiner B, Pomej K, Kirstein MM, Hucke F, Finkelmeier F, Waidmann O, Himmelsbach V, Schulze K, von Felden J, Fründt TW, Stadler M, Heinzl H, Shmanko K, Spahn S, Radu P, Siebenhüner AR, Mertens JC, Rahbari NN, Kütting F, Waldschmidt DT, Ebert MP, Teufel A, De Dosso S, Pinato DJ, Pressiani T, Meischl T, Balcar L, Müller C, Mandorfer M, Reiberger T, Trauner M, Personeni N, Rimassa L, Bitzer M, Trojan J, Weinmann A, Wege H, Dufour JF, Peck-Radosavljevic M, Vogel A, Pinter M

    Go to article

    Liver and Bile

    Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis

    Gut. 2022; 71(3):593–604

    Sapena V, Enea M, Torres F, Celsa C, Rios J, Rizzo GEM, Nahon P, Mariño Z, Tateishi R, Minami T, Sangiovanni A, Forns X, Toyoda H, Brillanti S, Conti F, Degasperi E, Yu ML, Tsai PC, Jean K, El Kassas M, Shousha HI, Omar A, Zavaglia C, Nagata H, Nakagawa M, Asahina Y, Singal AG, Murphy C, Kohla M, Masetti C, Dufour JF, Merchante N, Cavalletto L, Chemello LLC, Pol S, Crespo J, Calleja JL, Villani R, Serviddio G, Zanetto A, Shalaby S, Russo FP, Bielen R, Trevisani F, Cammà C, Bruix J, Cabibbo G, Reig M

    Go to article